Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a magnetic helmet curb impulsivity in veterans with ADHD?

NCT ID NCT07442058

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests a new, non-drug treatment for veterans with ADHD who still struggle with impulsivity despite medication. The treatment, called intermittent theta-burst stimulation (iTBS), uses magnetic pulses to gently stimulate brain areas linked to self-control. Thirty-five veterans will receive either real or sham stimulation to see if the approach is feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intermittent Theta-Burst Stimulation (iTBS), a type of transcranial magnetic stimulation
What this could lead to
If it works, this could point toward a drug-free way to help veterans with ADHD manage impulsivity and improve daily functioning.
What could go wrong
This is a very early, small feasibility study with only 35 participants. It is not yet recruiting, and the main goal is to see if the treatment is acceptable, not whether it works. There is also a risk that the sham (placebo) group shows similar results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of ADHD predominantly hyperactive-impulsive or combined, as outlined in the DSM-5-TR criteria * Maintenance of clinical symptoms despite receiving stable treatment for a minimum of 6 weeks before the study procedures * Capability to comprehend and provide informed consent * For safety reasons, participants must meet established screening criteria to ensure safety during Magnetic Resonance Imaging (MRI) scans * This precaution is taken due to the novel application of iTBS in this specific population, as MRI involves exposure to magnetic fields similar in intensity to those emitted from the stimulation coil * As such, participants must not have the following, unless the devices are MRI-safe: * cardiac pacemaker * implanted devices (such as deep brain stimulators) * metal in the brain * cervical spinal cord, or upper thoracic spinal cord level * In addition, eligible Veterans must also be able and willing to comply with all study procedures and visits * Throughout the study, pharmacologic and psychotherapeutic regimens will tentatively remain unchanged Exclusion Criteria: * Primary psychotic disorders, bipolar I disorder, ongoing severe substance use disorders, or active suicidality * Non-MRI safe cardiac pacemakers, implanted devices, or metallic implants at the upper thoracic spine level or higher * Any of the Transcranial Magnetic Stimulation (TMS) specific exclusion criteria, including: * pregnancy * lactation * planning pregnancy during period of study * history of moderate or severe traumatic brain injury * active unstable medical conditions * CNS tumors * seizures * cerebrovascular disease * other severe neurological disorders * Additional exclusion criteria include the presence of any other condition or circumstance that, as determined by the investigator team, has the potential to prevent study completion or introduce confounding effects in outcome assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit disorder with hyperactivity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Providence VA Medical Center, Providence, RI

    Providence, Rhode Island, 02908-4734, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.